Does LAMIVUDINE Cause Hyperphosphataemia? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Hyperphosphataemia have been filed in association with LAMIVUDINE (Lamivudine and Zidovudine). This represents 0.2% of all adverse event reports for LAMIVUDINE.
31
Reports of Hyperphosphataemia with LAMIVUDINE
0.2%
of all LAMIVUDINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Hyperphosphataemia From LAMIVUDINE?
Of the 31 reports.
Is Hyperphosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAMIVUDINE. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does LAMIVUDINE Cause?
Foetal exposure during pregnancy (1,905)
Virologic failure (1,894)
Drug resistance (1,889)
Pathogen resistance (1,733)
Viral mutation identified (1,631)
Treatment failure (933)
Exposure during pregnancy (846)
Drug interaction (744)
Drug ineffective (726)
Immune reconstitution inflammatory syndrome (625)
What Other Drugs Cause Hyperphosphataemia?
ALLOPURINOL (139)
LANSOPRAZOLE (138)
ACETAMINOPHEN (132)
SEVELAMER (129)
ONDANSETRON (127)
CALCITRIOL (125)
IPRATROPIUM (123)
ALBUTEROL (122)
METRONIDAZOLE (120)
HYDROMORPHONE (118)
Which LAMIVUDINE Alternatives Have Lower Hyperphosphataemia Risk?
LAMIVUDINE vs LAMIVUDINE\NEVIRAPINE\ZIDOVUDINE
LAMIVUDINE vs LAMIVUDINE\TENOFOVIR
LAMIVUDINE vs LAMIVUDINE\TENOFOVIR DISOPROXIL
LAMIVUDINE vs LAMIVUDINE\ZIDOVUDINE
LAMIVUDINE vs LAMOTRIGINE